Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikiProjectMed
Search

Myxedema

From WikiProjectMed
Extreme hypothyroidism
This article is about skin changes that occur in hypothyroidism. The word myxedema was historically used to referhypothyroidism in general. For the related medical emergency, seemyxedema coma.
Medical condition
Myxedema
Other namesMyxoedema
Hyaluronan, an example of amucopolysaccharide
SpecialtyEndocrinology

Myxedema (British English:myxoedema) is a term used synonymously with severehypothyroidism, but also to describe adermatological change that can occur in hypothyroidism and (rare)paradoxical cases ofhyperthyroidism. In this latter sense, myxedema refers to deposition ofmucopolysaccharides in thedermis, which results inswelling of the affected area. One manifestation of myxedema occurring in the lower limb ispretibial myxedema, a hallmark ofGraves disease, an autoimmune form ofhyperthyroidism. Myxedema can also occur inHashimoto thyroiditis and other long-standing forms ofhypothyroidism.

Signs and symptoms

Man with myxedema or severe hypothyroidism showing an expressionless face, puffiness around the eyes and pallor
Additional findings include swelling of the arms and legs and significantascites.
Woman with myxedema, Bulgaria, 1930s.

Myxedema's characteristic physical sign isnon-pitting edema, in contrast topitting edema.[1]

Myxedema can also occur in the lower leg (pretibial myxedema) and behind the eyes (exophthalmos).[citation needed]

Severe cases, requiring hospitalization can exhibit signs of hypothermia, hypoglycemia, hypotension, respiratory depression, and coma.[citation needed]

Causes

Myxedema is known to occur in various forms ofhypothyroidism, as well as hyperthyroidism, includingGraves disease. One of the hallmarks of Grave's disease is pretibial myxedema, myxedema of the lower limb.[2]

Myxedema is more common in women than in men.[3]

Myxedema can occur in:

Pathophysiology

Myxedema describes a specific form ofcutaneous anddermaledema secondary to increased deposition ofconnective tissue components. The connective fibres are separated by an increased amount of protein and mucopolysaccharides. This protein-mucopolysaccharide complex binds water, producing non-pitting boggy edema, in particular around eyes, hands, feet and in the supraclavicular fossae. This deposition involves not only the skin but also the tongue, myocardium, kidney medulla, lung, intestine and most other organs of the body (apart from the stomach).[6] Myxoedema is also responsible for the thickening of the laryngeal and pharyngeal mucous membranes, which results in thick slurred speech and hoarseness, both of which are seen commonly in hypothyroidism.[citation needed]

The accumulation ofglycosaminoglycans (GAGs) in the dermal tissues consists characteristically ofhyaluronic acid with very little change in the dermatan sulfate abundance and perhaps a decrease in chondroitin sulfate.[2] The tissue change in myxedema can be related directly to the physicochemical properties of hyaluronate. Its hygroscopic nature allows it to swell to one thousand times its dry weight when hydrated.[7]

The pathogenesis of generalized myxedema is thought to be fairly well understood and related to the deficiency of thyroid hormone,[8] but thepathogenesis of pretibial and orbital myxedema due to Grave's disease is not fully understood, however, two mechanisms predominate:

  • Fibroblast stimulation. It is thought that fibroblast stimulation by thethyroid stimulating hormone (TSH) receptor increases the deposition of glycosaminoglycan, which results in an osmoticedema and fluid retention. It is thought that many cells responsible for forming connective tissue react to increases in TSH levels.[9][10]
  • Lymphocyte stimulation. In Graves' thyroid disease, lymphocytes react against the TSH receptor by inappropriately producing thyroid-stimulating immunoglobulin (IgG; type II hypersensitivity). Lymphocytes react not only against thyroid receptors, but also any tissue with cells expressing the receptor. This can lead to tissue damage and scar tissue formation, explaining the deposition of glycosaminoglycans.[11]

Diagnosis

It is often possible to diagnose myxedema on clinical grounds alone. Characteristic symptoms are weakness, cold intolerance, mental and physical slowness, dry skin, typical facies, and hoarse voice. Results of the total serum thyroxine and free thyroxine index tests usually will confirm the diagnosis.[12]

Management

Primary treatment is prompted by the administration of adequate doses of either the thyroid hormoneL-thyroxine given intravenously or by givingliothyronine via a nasogastric tube. It is essential to identify and treat the condition precipitating the coma.[12]

Myxedema coma is rare but often fatal. It occurs most often in elderly women and may be mistaken for one of the chronic debilitating diseases common to this age group.[12]

Gabrilove et al demonstrated that histological skin changes can be observed within 3-4 weeks after initiating thyroid hormone replacement therapy with desiccated thyroid extract.[13] This was documented through skin biopsies performed on individuals with hypothyroidism both before and after treatment. The magnitude of these effects was related to the dose of thyroid hormone administered, and the rate at which this occurred depended on the amounts of material present at the outset.

Though the exact cause of myxedema is still unclear, a wealth of research has demonstrated the importance ofiodine.[14] In an important study[15] the researchers showed that in the myxedematous type of cretinism treatment with iodine normalizes thyroid function provided that the treatment is begun early in the postnatal period. If not, the prognosis remains dismal.[14]

History

Myxedema was first treated successfully in 1891 whenGeorge Redmayne Murray diagnosed a 46-year-old woman with the disease. He prescribed an extract from sheep thyroid. The patient improved significantly within a few weeks and lived another 28 years while taking the sheep thyroid extract.[16]

Etymology

The word myxedema originates fromμύξᾰ, meaning "mucus" or "slimy substance", andοἴδημα for "swelling".[citation needed]

References

  1. Bhutada, Abhishek S.; Kodankandath, Thomas V. (July 2022)."Clinical Manifestations of Severe Untreated Hypothyroidism".Cureus.14 (7) e26595.doi:10.7759/cureus.26595.ISSN 2168-8184.PMC 9354917.PMID 35936163.
  2. 12Berger, William D. James, Dirk M. Elston, Timothy G. (2011).Andrews' Diseases of the skin: clinical dermatology (11th ed.). [London]: Saunders/ Elsevier.ISBN 978-1-4377-0314-6.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. Schneider, Arthur S.; Kim, Philip A. Szanto; with special contributions by Sandra I.; Swanson, Todd A. (2009).Pathology (4th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 314.ISBN 978-1-4511-0906-1.
  4. "Pretibial Myxedema". Archived fromthe original on 2016-03-04. Retrieved2009-03-27.
  5. "Hypothyroidism".The Lecturio Medical Concept Library. Retrieved27 July 2021.
  6. Parving, H-H.; Helin, G.; Garbarsch, C.; Johansen, A.A.; Jensen, B. A.; Helin, P.; Lund, P.; Lyngsøe, J. (February 1982)."Acid Glycosaminoglycans in Myxoedema".Clinical Endocrinology.16 (2):207–210.doi:10.1111/j.1365-2265.1982.tb03166.x.PMID 6461440.
  7. Safer, J. D. (July 2011)."Thyroid hormone action on skin".Dermato-Endocrinology.3 (3):211–215.doi:10.4161/derm.3.3.17027 (inactive 15 August 2025).PMC 3219173.PMID 22110782.{{cite journal}}: CS1 maint: DOI inactive as of August 2025 (link)
  8. "Connective Tissue, Glycosaminoglycans, and Diseases the Thyroid". 1 August 1989.
  9. "Fibroblast".Genetics Home Reference. U.S. National Library of Medicine. 2014-05-05. Archived fromthe original on May 1, 2009. Retrieved2014-05-10.
  10. "Fibroblasts". Retrieved16 August 2018.
  11. "Lymphocytes".The Lecturio Medical Concept Library. Retrieved27 July 2021.
  12. 123McConahey, W. M. (March 1978). "Diagnosing and treating myxedema and myxedema coma".Geriatrics.33 (3):61–66.ISSN 0016-867X.PMID 624451.
  13. "THE HISTOGENESIS OF MYXEDEMA". August 1957.
  14. 12Lindholm, J.; Laurberg, P. (2011)."Hypothyroidism and Thyroid Substitution: Historical Aspects".Journal of Thyroid Research.2011 809341.doi:10.4061/2011/809341.PMC 3134382.PMID 21760981.
  15. Vanderpas, Jean B.; Rivera-Vanderpas, Maria T.; Bourdoux, Pierre; Luvivila, Kapata; Lagasse, Raphael; Perlmutter-Cremer, Noémi; Delange, François; Lanoie, Leo; Ermans, André M. (1986-09-25). "Reversibility of Severe Hypothyroidism with Supplementary Iodine in Patients with Endemic Cretinism".New England Journal of Medicine.315 (13):791–795.doi:10.1056/NEJM198609253151302.ISSN 0028-4793.PMID 3018564.
  16. "Eating Organs to Cure Disease".Tacomed.com. Archived fromthe original on 6 September 2017. Retrieved15 June 2017.

External links

Hypothyroidism
Hyperthyroidism
Graves' disease
Thyroiditis
Enlargement
Retrieved from "https://mdwiki.org/w/index.php?title=Myxedema&oldid=1312125280"

[8]ページ先頭

©2009-2025 Movatter.jp